Merck Completes Harpoon Therapeutics Acquisition and SOTU Talks Drug Price Caps

February 2024 Sets New Record for Biotech Equity: ~$8B of Paper; YTD Total ~$14 billion

Biotech Surging Without M&A News - Short Squeeze and Momentum Traders Moving the Market. XBI Short 50M Shares

Biotech Correlation To the 10-Year: Broken in 2024...Will it Stay That Way?

5 Follow-On Transactions Highlight More Bullish Activity in the Biotech/Pharma Market

A Deep Dive Into Residential Real Estate - Bullet Points, Charts, and Graphs, Oh My!

Nearly $7B in M&A Transactions for February. The Search for Diversification Continues

Gilead Acquires Cymabay Therapeutics for $4.3B. Pharma Keeps Looking for Differentiated Assets

Novartis Acquires Morphosys in 2.8B Euro Deal.

$4B in Biotech Fundraising in January; $12B Run Rate for Q1. Biotech Moving with M&A